Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
Phenotypes
Genetic Variation
- Variant table
- Variant image
- Structural variants
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: SPIRE1 ENSPTRG00000009881

.

Description

spire type actin nucleation factor 1 [Source:VGNC Symbol;Acc:VGNC:7332]

Location

Chromosome 18: 5,274,671-5,505,472 forward strand.

Pan_tro_3.0:CM000332.3

About this gene

This gene has 4 transcripts (splice variants), 291 orthologues and 1 paralogue.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSPTRT00000095280.1	SPIRE1-201	2271	756aa	ENSPTRP00000079251.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A2I3SQL1 A0A6D2WNU8	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical, APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1,
ENSPTRT00000018148.5	SPIRE1-204	4986	583aa	ENSPTRP00000016811.5	Gene/transcipt that contains an open reading frame (ORF).Protein coding	H2QEA3	-
ENSPTRT00000079566.1	SPIRE1-203	1962	653aa	ENSPTRP00000076947.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A2I3SIW4	-
ENSPTRT00000101506.1	SPIRE1-202	1638	545aa	ENSPTRP00000091380.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A2I3TQ60 A0A6D2XL99	-

.

Summary

.

.